• Home
  • Explicat Pharma GmbH

Explicat Pharma GmbH

About Explicat Pharma GmbH

Explicat supports, advises and assists pharmaceutical companies, manufacturers, developers and laboratories around the world.
Our broad range of services include:

Technical Project Management
Pharmaceutical Development
Medical Device Development
Formulation Development
Technical Due Diligence
Qualified Person Services
Process Ana...

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • DE
  • 2015
    On CPHI since
  • 1 - 24
    Employees
Company types
Contract Service
View company profile
Contact info
Show contact info Hide contact info

Products from Explicat Pharma GmbH (3)

  • Technical Due Diligence

    Product Technical Due Diligence

    For companies that are:

    • Buying a Product outright • In-licensing a Product • Acquiring or Licensing Technology • Acquiring a Division • Acquiring a whole Company

    To cover the wide range of disciplines involved in Technical Due Diligence, Explicat® Pharma provides clien...
  • Consulting and advisory services for gmp, risk analysis, new product development strategy

    Product Consulting and advisory services for gmp, risk analysis, new product development strategy

    Explicat Pharma GmbH offers consulting and advisory services for gmp, risk analysis, new product development strategypharmaceutical services. Contact us for more information.
  • Technical Project Management

    Product Technical Project Management

    “You have an early development candidate – we take the responsibility to develop it and get it on the market”

    We use an integrated fast-track drug development approach to achieve this goal.

    • Sourcing • Chemical Development / Biotechnological Development • Pharmaceutical Develo...

Explicat Pharma GmbH Resources (1)

  • A CASE STUDY TO OPTIMIZE FREEZE DRYINGCONDITIONS OF CYCLODEXTRIN-BASED FORMULATIONS

    Whitepaper A CASE STUDY TO OPTIMIZE FREEZE DRYINGCONDITIONS OF CYCLODEXTRIN-BASED FORMULATIONS

    SBECD (Sulfobutylether - β - Cyclodextrin) is a new andpromising excipient for freeze dried formulations. Thepresent study illustrates an approach to optimize freezedrying conditions for formulations containing SBECD.First, a placebo was used to evaluate a general freezedrying recipe. Further, the information gained wascompared with drug product runs.
    (PDF) A CASE STUDY TO OPTIMIZE FREEZE DRYING CONDITIONS OF CYCLODEXTRIN-BASED FORMULATIONS. Available from: https://www.researchgate.net/publication/331642211_A_CASE_STUDY_TO_OPTIMIZE_FREEZE_DRYING_CONDITIONS_OF_CYCLODEXTRIN-BASED_FORMULATIONS [accessed Jul 26 2023].